United Therapeutics (UTHR) Tops Q2 EPS by 22c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $488.74 -1.78%
Revenue Growth %: -1.2%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -1.2%
Financial Fact:
Net product sales: 408.2M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $1.34, $0.22 better than the analyst estimate of $1.12. Revenue for the quarter came in at $225.6 million versus the consensus estimate of $213.33 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- On Holding AG (ONON) Stock: Market Doesn't Appreciate Brand's Potential, Says Analyst
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
